Drugs and biologics of 2009
April 2010
Our popular annual report on new chemical entities and biologics that reached the market in 2009 is now available.
The Year's New Drugs & Biologics—drawn from Thomson Reuters Integrity—features essential information on the 51 new medicines and vaccines that reached their first markets in 2009.
In the free, 30-page report, you'll find:
- A comprehensive review of the new drugs and biologics including line extensions and first-in-class drugs
- Predictions of which drugs will make it to market in 2010
- Essential background on Immunomodulators and Agents for Immunization—the most active therapeutic group, due to H1N1 response
- An overview of drug repositioning as a strategy for extending drug life spans
The Year's New Drugs & Biologics – 2009: register to receive your free copy by email
Additional information
The Year's New Drugs & Biologics – 2009: register to receive your free copy by email